Showing 34,980 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

People & personal stories

Paul Farmer, Pioneer of Global Health, Dies at 62

Editor's pick
The New York Times
23 February 2022

CROI 2022: Ulteriori evidenze a favore del reimpiego del tenofovir nel trattamento di seconda linea, Mercoledì 23 febbraio 2022

February 2022

CROI 2022: Más pruebas que respaldan la reutilización de tenofovir en tratamientos de segunda línea, Miércoles, 23 de febrero de 2022

February 2022

CROI 2022: Des données supplémentaires justifient le recyclage du ténofovir en traitement de deuxième intention, Mercredi 23 février 2022

February 2022

CROI 2022: Mais evidências apoiam a reutilização do tenofovir no tratamento de segunda linha, Quarta-feira, 23 de fevereiro de 2022

February 2022
How HIV works

COVID-19 genetic risk variant protects against HIV

Editor's pick
EurekAlert
23 February 2022
Injectable & long-acting PrEP

Start planning HIV prevention injection rollout, South African experts say

Editor's pick
Spotlight
23 February 2022
Migrants, refugees & displaced people

New report on tuberculosis, HIV and viral hepatitis services for refugees and migrants across the WHO European Region

Editor's pick
World Health Organization
23 February 2022
Finance & funding

Increase funding or abandon hope of ending malaria, TB and Aids, UK warned

Editor's pick
The Guardian
23 February 2022
Antibody-based treatment

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

News
23 February 2022

КРОИ 2022: Больше данных в поддержку реутилизации тенофовира в схемах второго выбора, Среда, 23 февраля 2022 г.

February 2022

CROI 2022: More evidence to support recycling tenofovir in second-line treatment, Wednesday 23 February 2022

February 2022
Global health initiatives

Five African Presidents Launch Global Fund's US$18 Billion Campaign to Restore Progress Against AIDS, TB and Malaria Amid COVID-19 Disruption

Editor's pick
The Global Fund
23 February 2022
The search for an HIV prevention vaccine

Why did an HIV vaccine fail in the Imbokodo trial?

News
23 February 2022
New & experimental HIV treatments

Lenacapavir shows continued promise for first-line treatment and highly resistant HIV

News
23 February 2022
Injectable & long-acting PrEP

Injected PrEP: breakthrough cases could have been detected sooner

News
22 February 2022
Neurological & cognitive problems

Have HIV-associated neurological disorders declined in people with HIV due to recent antiretrovirals?

News
22 February 2022
Changing treatment

Further evidence that recycling tenofovir in second-line treatment is effective

News
22 February 2022
People & personal stories

Remembering Dr. Paul Farmer, world-renowned infectious disease doctor, anthropologist, global health advocate, and author

Editor's pick
Partners in Health
21 February 2022
Epidemiology

Fact Check - Posts saying straight people are more at risk of HIV infection misrepresent data

Editor's pick
Reuters
21 February 2022
Drug-resistant TB

Fewer Pills Plus Shorter Time: New Way to Control Drug-Resistant TB?

Editor's pick
MedPage Today
21 February 2022
Ageing & HIV

Marc Thompson: Still Here After All These Years

Editor's pick
Infectious Disease Special Edition
21 February 2022

КРОИ 2022: Скрининг и своевременная терапия предраковых изменений снижает уровень анального рака у ВИЧ-инфицированных лиц, Пятница, 18 февраля 2022 г.

February 2022

CROI 2022: Screening e trattamento precoce per ridurre il cancro anale nelle persone HIV-positive, Venerdì 18 febbraio 2022

February 2022